Pfizer Inc. and Astellas Pharma Inc. announced the phase III PROSPER trial evaluating XTANDI (enzalutamide) plus androgen deprivation therapy versus ADT alone in patients with non-metastatic castration-resistant prostate cancer met its primary endpoint of improved metastasis-free survival.
A new Cleveland Clinic study underscores the importance of early detection and treatment of melanoma, the deadliest form of skin cancer.
An analysis led by researchers at Fox Chase Cancer Center in collaboration with the European Organization for the Research and Treatment of Cancer found that treating cancer that has metastasized to the brain with focal, high-dose radiation yields improved early results compared with surgical removal.
Treatment with trastuzumab (Herceptin/Genentech) of breast cancers that express the HER-2 protein does not increase the risk for complications at the surgical site for women who undergo immediate breast reconstruction after mastectomy.
A recent study confirmed the International Association for the Study of Lung Cancer's proposed criteria for uncertain resection margin status, R(un), in residual tumor (R) classification.
The Trump administration should consider NIH and the biomedical research enterprise as a component of the nation's “defense” when making budgetary decisions, said Rep. Tom Cole (R-OK), chairman of the House Appropriations Subcommittee for Labor-HHS, Education, and Related Agencies.
With a month to go before his Dec. 1 start date as president of MD Anderson Cancer Center, Peter Pisters reflected on the challenges that await him in Houston.
MD Anderson has begun a search for a chief academic officer.
Ethan Dmitrovsky was appointed president Leidos Biomedical Research, Inc. and Laboratory director of the Frederick National Laboratory for Cancer Research.
The disparity in survival outcomes between black and white women with breast cancer—the result of a complex interaction of biologic and nonbiologic factors—can be reduced by increasing access to health care in all U.S. states, researchers from the American Cancer Society concluded in a recent study.
